Autoreactivity by design: Innate B and T lymphocytes

Nature Reviews Immunology

Volumn 1, Issue 3, 2001, Pages 177-186

  Bendelac, Albert ^a   Bonneville, Marc ^b   Kearney, John F ^c  

^a PRINCETON UNIVERSITY   (United States)

^b INSTITUT DE BIOLOGIE   (France)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL; AUTOIMMUNITY; B LYMPHOCYTE; BIOLOGICAL MODEL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; REVIEW; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; AUTOANTIGENS; AUTOIMMUNITY; B-LYMPHOCYTE SUBSETS; HUMANS; MODELS, IMMUNOLOGICAL; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, ANTIGEN, T-CELL; SELF TOLERANCE; T-LYMPHOCYTE SUBSETS;

EID: 0035753991     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/35105052     Document Type: Review

References (101)

1. Medzhitov, R. & Janeway, C. A. Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell 91, 295-298 (1997).
2. Benlagha, K. & Bendelac, A. CD1d-restricted mouse Vα14 and human Vα24 T cells: lymphocytes of innate immunity. Semin. Immunol. 12, 537-542 (2000).
3. Hayakawa, K. et al. Positive selection of natural autoreactive B cells. Science 285, 113-116 (1999). The first demonstration that self-antigen drives the selection of innate lymphocytes.
4. Briles, D. E. et al. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae. J. Exp. Med. 153, 694-705 (1981). The first demonstration that innate lymphocytes confer natural protection against infection.
5. Shaw, P. X. et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J. Clin. Invest. 105, 1731-1740 (2000).
6. Martin, F. & Kearney, J. F. B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a 'natural immune memory'. Immunol. Rev. 175, 70-79 (2000).
7. + T lymphocytes. Science 268, 863-865 (1995).
8. Smiley, S. T., Kaplan, M. H. & Grusby, M. J. Immunoglobulin E production in the absence of interleukin-4 secreting CD1-dependent cells. Science 275, 977-979 (1997).
9. Park, S. H. et al. The mouse CD1d-restricted repertoire is dominated by a few autoreactive T cell receptor families. J. Exp. Med. 193, 893-904 (2001). The intriguing demonstration that most of the mouse CD1d-restricted T-cell receptor repertoire is innate rather than adaptive.
10. Chiu, Y. H. et al. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J. Exp. Med. 189, 103-110 (1999).
11. Kawano, T. et al. CD1d-restricted and TCR-mediated activation of vα14 NKT cells by glycosylceramides. Science 278, 1626-1629 (1997).
12. Groh, V., Steinle, A., Bauer, S. & Spies, T. Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells. Science 279, 1737-1740 (1998).
13. Spada, F. M. et al. Self-recognition of CD1 by γ/δ T cells: implications for innate immunity. J. Exp. Med. 191, 937-948 (2000).
14. Crowley, M. P. et al. A population of murine γδ T cells that recognize an inducible MHC class Ib molecule. Science 287, 314-316 (2000).
15. Bauer, S. et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727-729 (1999).
16. + (CD5) B cells that recognize phosphatidylcholine. Relationship to cells that secrete hemolytic antibody specific for autologous erythrocytes. J. Exp. Med. 168, 687-698 (1988).
17. Hardy, R. R., Carmack, C. E., Shinton, S. A., Riblet, R. J. & Hayakawa, K. A single VH gene is utilized predominantly in anti-BrMRBC hybridomas derived from purified Ly-1 B cells. Definition of the VH11 family. J. Immunol. 142, 3643-3651 (1989).
18. Constant, P. et al. Stimulation of human γδ T cells by nonpeptidic mycobacterial ligands. Science 264, 267-270 (1994).
19. Fournie, J. J. & Bonneville, M. Stimulation of γδ T cells by phosphoantigens. Res. Immunol. 147, 338-347 (1996).
20. Allison, T. J., Winter, C. C., Fournie, J. J., Bonneville, M. & Garboczi, D. N. Structure of a human γδ TCR. Nature 411, 820-824 (2001).
21. Lang, F. et al. Early activation of human Vγ9Vδ2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands. J. Immunol. 154, 5986-5994 (1995).
22. Morita, C. T. et al. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human γδ T cells. Immunity 3, 495-507 (1995).
23. Havran, W. L. A role for epithelial γδ T cells in tissue repair. Immunol. Res. 21, 63-69 (2000).
24. Havran, W. L., Chien, Y. H. & Allison, J. P. Recognition of self antigens by skin-derived T cells with invariant γδ antigen receptors. Science 252, 1430-1432 (1991).
25. Mukasa, A., Lahn, M., Pflum, E. K., Born, W. & O'Brien, R. L. Evidence that the same γδ T cells respond during infection-induced and autoimmune inflammation. J. Immunol. 159, 5787-5794 (1997).
26. Allison, J. P. & Havran, W. L. The immunobiology of T cells with invariant γδ antigen receptors. Annu. Rev. Immunol. 9, 679-705 (1991).
27. Mallick-Wood, C. A. et al. Conservation of T cell receptor conformation in epidermal γδ cells with disrupted primary Vγ gene usage. Science 279, 1729-1733 (1998).
28. Watanabe, N. et al. Migration and differentiation of autoreactive B-1 cells induced by activated γ/δ T cells in antierythrocyte immunoglobulin transgenic mice. J. Exp. Med. 192, 1577-1586 (2000).
29. Haas, W., Pereira, P. & Tonegawa, S. γ/δ cells. Annu. Rev. Immunol. 11, 637-685 (1993).
30. Hayday, A. C. γδ cells: a right time and a right place for a conserved third way of protection. Annu. Rev. Immunol. 18, 975-1026 (2000). An up-to-date authoritative review on γδ T cells.
31. Boismenu, R. & Havran, W. L. Modulation of epithelial cell growth by intraepithelial γδ T cells. Science 266, 1253-1255 (1994). A demonstration of the crosstalk between tissues and their resident lymphocytes.
32. Azuara, V., Levraud, J. P., Lembezat, M. P. & Pereira, P. A novel subset of adult γδ thymocytes that secretes a distinct pattern of cytokines and expresses a very restricted T cell receptor repertoire. Eur. J. Immunol. 27, 544-553 (1997).
33. Brown, M. G., Scalzo, A. A., Matsumoto, K. & Yokoyama, W. M. The natural killer gene complex: a genetic basis for understanding natural killer cell function and innate immunity. Immunol. Rev. 155, 53-65 (1997).
34. Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N. & Raulet, D. H. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nature Immunol. 1, 119-126 (2000).
35. Halary, F. et al. Control of self-reactive cytotoxic T lymphocytes expressing γδ T cell receptors by natural killer inhibitory receptors. Eur. J. Immunol. 27, 2812-2821 (1997). A demonstration that inhibitory receptors control autoreactive T-cell receptors.
36. Ikarashi, Y. et al. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition. Critical role for b7 in CD1d-dependent NKT cell interferon γ production. J. Exp. Med. 194, 1179-1186 (2001).
37. Exley, M., Porcelli, S., Furman, M., Garcia, J. & Balk, S. CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant Vα24JαQ T cell receptor α chains. J. Exp. Med. 188, 867-876 (1998).
38. Schuhmachers, G. et al. 2B4, a new member of the immunoglobulin gene superfamily, is expressed on murine dendritic epidermal T cells and plays a functional role in their killing of skin tumors. J. Invest. Dermatol. 105, 592-596 (1995).
39. Girardi, M. et al. Regulation of cutaneous maligancy by γδ T cells. Science 294, 605-609 (2001).
40. Bikah, G., Carey, J., Ciallella, J. R., Tarakhovsky, A. & Bondada, S. CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science 274, 1906-1909 (1996).
41. Sen, G., Bikah, G., Venkataraman, C. & Bondada, S. Negative regulation of antigen receptor-mediated signaling by constitutive association of CD5 with the SHP-1 protein tyrosine phosphatase in B-1 B cells. Eur. J. Immunol. 29, 3319-3328 (1999).
42. Reap, E. A., Sobel, E. S., Cohen, P. L. & Eisenberg, R. A. Conventional B cells, not B-1 cells, are responsible for producing autoantibodies in lpr mice. J. Exp. Med. 177, 69-78 (1993).
43. 1 mice. Clin. Immunol. 94, 51-63 (2000).
44. Paciorkowski, N., Porte, P., Shultz, L. D. & Rajan, T. V. B1 B lymphocytes play a critical role in host protection against lymphatic filarial parasites. J. Exp. Med. 191, 731-736 (2000).
45. Rosen, A. & Casciola-Rosen, L. Clearing the way to mechanisms of autoimmunity. Nature Med. 7, 664-665 (2001).
46. + B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. Eur. J. Immunol. 17, 521-528 (1987).
47. Ochsenbein, A. F. et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science 286, 2156-2159 (1999).
48. Weiser, M. R. et al. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J. Exp. Med. 183, 2343-2348 (1996).
49. King, D. P. et al. Cutting edge: protective response to pulmonary injury requires γδ T lymphocytes. J. Immunol. 162, 5033-5036 (1999).
50. D'Souza, C. D. et al. An anti-inflammatory role for γδ T lymphocytes in acquired immunity to Mycobacterium tuberculosis. J. Immunol. 158, 1217-1221 (1997).
51. +-like thymocytes in the NOD mouse. Eur. J. Immunol. 26, 2989-2998 (1996).
52. H1 bias of invariant Vα24JαQ T cells in type I diabetes. Nature 391, 177-181 (1998).
53. Shi, F. D. et al. Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse. Proc. Natl Acad. Sci. USA 98, 6777-6782 (2001).
54. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interteukin (IL)-4 and/or IL-10. J. Exp. Med. 187, 1047-1056 (1998).
55. Lehuen, A. et al. Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188, 1831-1839 (1998).
56. Smyth, M. J. et al. Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med 191, 661-668 (2000).
57. Terabe, M. et al. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nature Immunol. 1, 515-520 (2000).
58. Dieli, F. et al. Resistance of natural killer T cell-deficient mice to systemic Shwartzman reaction. J. Exp. Med. 192, 1645-1652 (2000).
59. Carnaud, C. et al. Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163, 4647-4650 (1999).
60. Kitamura, H. et al. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interteukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189, 1121-1128 (1999).
61. Park, S. H. & Bendelac, A. CD1-restricted T-cell responses and microbial infection. Nature 406, 788-792 (2000).
62. Havran, W. L. & Allison, J. P. Developmentally ordered appearance of thymocytes expressing different T-cell antigen receptors. Nature 335, 443-445 (1988).
63. Zhang, Y. et al. The role of short homology repeats and TdT in generation of the invariant γδ antigen receptor repertoire in the fetal thymus. Immunity 3, 439-447 (1995). Genetic dissection of the making of a canonical T-cell receptor.
64. Itohara, S. et al. T cell receptor δ gene mutant mice: independent generation of αβ T cells and programmed rearrangements of γδ TCR genes. Cell 72, 337-348 (1993).
65. Benedict, C. L. & Kearney, J. F. Increased functional diversity in fetal B cells results in a loss of protective anti-phosphorylcholine antibodies in adult mice. Immunity 10, 607-617 (1999). Genetic dissection of the making of a canonical B-cell receptor.
66. - T cells in mice and humans. J. Exp. Med. 180, 1097-1106 (1994).
67. + T cells. Eur. J. Immunol. 27, 1576-1579 (1997).
68. McVay, L. D. & Carding, S. R. Extrathymic origin of human γδ T cells during fetal development. J. Immunol. 157, 2873-2882 (1996).
69. Parker, C. M. et al. Evidence for extrathymic changes in the T cell receptor γ/δ repertoire. J. Exp. Med. 171, 1597-1612 (1990).
70. Davodeau, F. et al. Peripheral selection of antigen receptor junctional features in a major human γδ subset. Eur. J. Immunol. 23, 804-808 (1993).
71. Tatu, C., Ye, J., Arnold, L. W. & Clarke, S. H. Selection at multiple checkpoints focuses V(H)12 B cell differentiation toward a single B-1 cell specificity. J. Exp. Med. 190, 903-914 (1999).
72. Lam, K. P. & Rajewsky, K. B cell antigen receptor specificity and surface density together determine B-1 versus B-2 cell development. J. Exp. Med. 190, 471-477 (1999).
73. + B cells both in vivo and in vitro. J. Immunol. 164, 4586-4593 (2000).
74. Martin, F. & Kearney, J. F. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity 12, 39-49 (2000). A demonstration that specificity and avidity for self-antigen control the differentiation of innate lymphocytes.
75. Gerber, D. J. et al. IL-4-producing γδ T cells that express a very restricted TCR repertoire are preferentially localized in liver and spleen. J. Immunol. 163, 3076-3082 (1999).
76. Bendelac, A., Hunziker, R. D. & Lantz, O. Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells. J. Exp. Med. 184, 1285-1293 (1996).
77. + T cells with a transgenic variant TCR. J. Immunol. 165, 168-174 (2000).
78. Bonneville, M. et al. Transgenic mice demonstrate that epithelial homing of γ/δ T cells is determined by cell lineages independent of T cell receptor specificity. J. Exp. Med. 171, 1015-1026 (1990).
79. Watanabe, N. et al. Expression levels of B cell surface immunoglobulin regulate efficiency of allelic exclusion and size of autoreactive B-1 cell compartment. J. Exp. Med. 190, 461-469 (1999).
80. Kouskoff, V. Lacaud, G., Pape, K., Retter, M. & Nemazee, D. B cell receptor expression level determines the fate of developing B lymphocytes: receptor editing versus selection. Proc. Natl Acad. Sci. USA 97, 7435-7439 (2000).
81. Kenny, J. J. et al. Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors. J. Immunol. 164, 4111-4119 (2000).
82. + thymocytes selected by MHC class I molecules. Science 263, 1774-1778 (1994).
83. Kennedy, M. K. et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191, 771-780 (2000).
84. Oyster, J. G. & Goodnow, C. C. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 2, 13-24 (1995).
85. Hayakawa, K. & Hardy, R. R. Development and function of B-1 cells. Curr. Opin. Immunol. 12, 346-353 (2000).
86. Murakami, M. et al. Effects of breeding environments on generation and activation of autoreactive B-1 cells in anti-red blood cell autoantibody transgenic mice. J. Exp. Med. 185, 791-794 (1997).
87. + T cells upon antigen expression in the thymus or in the liver. Eur. J. Immunol. 29, 2330-2343 (1999).
88. + T lymphocytes. Thymic selection by self antigen. J. Immunol. 157, 4379-4389 (1996).
89. Galili, U. Evolution and pathophysiology of the human natural anti-α-galactosyl IgG (anti-Gal) antibody. Springer Semin. Immunopathol. 15, 155-171 (1993).
90. Liu, Y. J., Oldfield, S. & MacLennan, I. C. Memory B cells in T cell-dependent antibody responses colonize the splenic marginal zones. Eur. J. Immunol. 18, 355-362 (1988).
91. MacLennan, I. C. & Gray, D. Antigen-driven selection of virgin and memory B cells. Immunol. Rev. 91, 61-85 (1986).
92. Litman, G. W. et al. Immunoglobulin VH gene structure and diversity in Heterodontus, a phylogenetically primitive shark. Proc. Natl Acad. Sci. USA 82, 2082-2086 (1985).
93. Matzinger, P. Tolerance, danger and the extended family. Annu. Rev. Immunol. 12, 991-1045 (1994). A general model of immunity based on the assumption that sensing tissue stress and damage governs the decision between immunological tolerance versus responsiveness.
94. Gallucci, S., Lolkema, M. & Matzinger, P. Natural adjuvants: endogenous activators of dendritic cells. Nature Med. 5, 1249-1255 (1999). A demonstration that necrotic, but not apoptotic, cell death activates the immune system.
95. H2 phenotype. J. Immunol. 163, 2373-2377 (1999).
96. Kakimi, K., Guidotti, L. G., Koezuka, Y. & Chisari, F. V. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192, 921-930 (2000).
97. Gonzalez-Aseguinolaza, G. et al. α-galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria. Proc. Natl Acad. Sci. USA 97, 8461-8466 (2000).
98. Toura, I. et al. Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with α-galactosylceramide. J. Immunol. 163, 2387-2391 (1999).
99. Hong, S. et al. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in nonobese diabetic mice. Nature Med. 7, 1052-1056 (2001).
100. Sharif, S. et al. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nature Med. 7, 1057-1062 (2001).
101. H2 bias of natural killer T cells. Nature 413, 531-534 (2001).